Cargando…
Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial
Because cladribine can increase cytarabine triphosphate levels, we tested a cladribine—cytarabine combination in the St. Jude AML97, trial in which this combination was administered before standard chemotherapy to 96 children with acute myeloid leukemia (AML) or myelodysplastic syndrome. Patients re...
Autores principales: | Rubnitz, Jeffrey E., Crews, Kristine R., Pounds, Stanley, Yang, Shengping, Campana, Dario, Gandhi, Varsha V., Raimondi, Susana C., Downing, James R., Razzouk, Bassem I., Pui, Ching-Hon, Ribeiro, Raul C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726271/ https://www.ncbi.nlm.nih.gov/pubmed/19242495 http://dx.doi.org/10.1038/leu.2009.30 |
Ejemplares similares
-
Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML
por: Bargal, Salma A., et al.
Publicado: (2018) -
DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
por: Lamba, Jatinder K., et al.
Publicado: (2020) -
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen
por: Libura, Marta, et al.
Publicado: (2021) -
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
por: Halpern, Anna B., et al.
Publicado: (2023) -
Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
por: Pui, C-H, et al.
Publicado: (2009)